The clinical research about early diagnosis of small cell lung cancer through mad2 de-tection
10.3969/j.issn.1000-8179.2018.02.104
- VernacularTitle:mad2检测作为小细胞肺癌早期诊断潜在指标的临床研究
- Author:
Wu YANG
1
;
Liming TAN
;
Juanjuan CHEN
;
Hua LI
;
Houqun YIN
;
Yongqin JIANG
;
Qiong WU
;
Guofang YU
;
Yongjian TIAN
;
Jianlin YU
;
Tingting ZENG
;
Lingxian YAN
;
Chuan LIU
Author Information
1. 南昌大学第二附属医院检验科
- Keywords:
small cell lung cancer(SCLC);
mitotic arrest deficient 2(mad2);
anti-nuclear mitotic spindle apparatus antibody(MSA);
anti-centromere antibody(ACA)
- From:
Chinese Journal of Clinical Oncology
2018;45(2):67-71
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore combined detection of mad2 with anti-nuclear mitotic spindle apparatus antibody(MSA)and anti-centromere antibody(ACA)and their clinical value for the diagnosis of small cell lung cancer(SCLC).Methods:One hundred and twen-ty SCLC patients,110 non-small cell lung cancer(NSCLC)patients,and 115 pulmonary nodule(PN)patients were enrolled in this study. The expression of mad2 was analyzed by qt-PCR.MSA and ACA were detected by indirect immunofluorescence(IIF)staining.Results:mad2 was overexpressed in SCLC and NSCLC samples(P<0.05).There were significant differences between the results obtained for SCLC and NSCLC samples by qt-PCR(P<0.05).AUC in ROC curve for mad2 expression was 0.799 with an intermediate diagnostic value. In the correlative analysis,the odds ratio of MSA and ACA was 6.94 and 5.60,respectively.In the correlation analysis,Kappa value of mad2 with MSA was 0.49,and Kappa value of mad2 with ACA was 0.42.In the parallel analysis,the sensitivity and specificity was 83.31% and 79.34%,respectively,while the Youden Index was 0.62.Moreover,in the serial analysis,the sensitivity and specificity was 65.32% and 93.35%,respectively,and the Youden Index was 0.59.Conclusions:In comparison with the NSCLC and PN samples,mad2 was overexpressed in SCLC samples.Therefore,mad2 ought to play a critical role in the pathology of SCLC.The combined expression of mad2 with MSA and ACA may contribute to enhancing the sensitivity and specificity of detection;this expression may allow early diag-nosis and clinical diagnosis of SLCC and may be a promising treatment for SCLC.
